To study the effect of Maghadadyam churna in Tamak shwas with special reference to Bronchial asthma

Phase 3

Not yet recruiting

• Conditions: Other and unspecified asthma. Ayurveda Condition: TAMAKASVASAH,

• Registration Number: CTRI/2025/04/085284
• Lead Sponsor: Dr Sashank Sukdatta Borkar

Brief Summary

This is  Randomised open controlled clinical trial to evaluate the Efficacy of Maghadadyam Churna  in Tamak Shwasa w.s.r to Bronchial Asthma

The assesment of signs and symptoms will be done at regular follow ups

Observations will be drawn from the outcomes achieved in 30 days

Detailed Description

Not available

Study Timeline

• Study Start: 2025-06-05
• Last Update Posted: 2025-08-04

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• All the subjects of all gender between 18 to 60 years of age All diagnosed with Tamak shwas as per Ayurveda Classical symptoms as shwas ghurghurakam vega 3.
• Patients having FEV1 greater than 80 percent of predicted.

Exclusion Criteria

Having any major illness and known history of TB IHD CCF HTN DM HIV COVID Asbestosis Silicosis Severe asthamatic patients in avegavashtha.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To Study the effect of Maghadadyam Churna with madhu internally in Tamak Shwasa by assesing Shwasa vega ghurghurakam FEV1	30 days

Secondary Outcome Measures

Name	Time	Method
1)To study Tamak shwasa in details from various Ayurvedic Texts	2)To study efficacy of Maghadadyam churna in signs of shwas,ghurghurakam,kasa in Tamak shwasa

Trial Locations

Locations (1)

Yashwant Dharmartha Rugnalaya; 🇮🇳 Kolhapur, MAHARASHTRA, India

Yashwant Dharmartha Rugnalaya

🇮🇳Kolhapur, MAHARASHTRA, India

Dr Shashank Sukdatta Borkar

Principal investigator

9075645686

shashank101297@gmail.com